BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Platelet-to-Neutrophil Ratio Emerges as Key Diagnostic Marker for Diabetic Macular Edema: Study Finds Medha Baranwal8 April 2025 8:00 AM ISTChina: A recent study has illuminated the potential of the platelet-to-neutrophil ratio (PNR) as a diagnostic tool in identifying diabetic macular...
Bayer files for approval of extended 6 month treatment interval for Eylea 8 mg in EU Ruchika Sharma11 Feb 2025 11:30 AM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea...
FDA approves ranibizumab for treating diabetic macular edema Dr. Kamal Kant Kohli5 Feb 2025 8:30 PM ISTThe U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the treatment of diabetic macular...
Intas Pharmaceutical gets CDSCO Panel nod to study Aflibercept Solution for Injection 40 mg/ml in Vial Dr. Divya Colin15 Dec 2024 6:00 PM ISTNew Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional Central Drug Standard Control Organisation...
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale Multicenter Study with 2194 injections in 1401 eyes MDTV Bureau6 Dec 2024 12:19 PM ISTReal-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) is a safe...
Intravitreal Aflibercept and Faricimab decreases ocular blood flow to optic nerve head and peripapillary retinal vessels: Study Dr Ishan Kataria18 Nov 2024 8:00 PM ISTDiabetic retinopathy (DR) is the primary cause of visual impairment among working-age populations in industrialized nations. Vision loss may result...
Merck, EyeBio announce initiation of Phase 2b/3 clinical trial for Restoret for Diabetic Macular Edema Ruchika Sharma8 Sept 2024 4:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned subsidiary of Merck & Co., Inc., Rahway,...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
New eye drops found safe and effective in diabetic retinopathy and diabetic macular edema in New trial Dr. Kamal Kant Kohli14 March 2024 1:15 AM ISTNew eye drop treatment has been found to be safe and tolerable with 100% participants completing the study for diabetic retinopathy and diabetic...
Roche Pharma India forays into Ophthalmology space with launch of Vabysmo Ruchika Sharma6 March 2024 4:10 PM ISTAs the world's first bispecific antibody, Vabysmo is a single molecule designed to target and inhibit the effects of two targets, providing the...
